Top panels illustrate mechanisms of action: atropine (2.1 mg) competitively antagonizes acetylcholine at muscarinic receptors to reverse cholinergic effects (e.g., bronchorrhea, bronchospasm, bradycardia), while pralidoxime (2PAM, 600 mg) reactivates acetylcholinesterase by cleaving the nerve agentenzyme bond prior to irreversible aging. Middle panels depict the dualchamber autoinjector design, which contains atropine and pralidoxime in separate compartments and delivers both drugs sequentially via a springloaded intramuscular mechanism from a single needle
Linebarger: So I think that I would say patients, wherever they go, should not pay any more than $400 for a bottle of it to last 30 to 60 days
Das ist jedoch nicht zwingend richtig
Andersen JM, Ronning PO, Herning H, Bekken SD, Haugen TB, Witczak O